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Introduction
Human lymphoma cells show an increased
mutation in the protein CBP. To understand
the relationship between CBP and CARM1
they are both investigated by having their
gene expression lowered. It has been noted
that within lymphoma cells CBP is mutated
and for the cell survival CARM1 methylates
CBP. Within this experiment, RL WT and
RL CBP KO cells are examined.

DNA Sequencing of Annealed Oligo Inside Plasmid

This is the lentiCRISPRv2 plasmid. Within the bottom right region, the Cas9 mechanism, Puromycin
resistance gene and filler can be seen.

Bacteria Transformation

Objective
The goal behind this study is to further
understand the relationship between CBP
and CARM1 by creating CARM1 CRISPR
KO cells.
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•
•
•
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•
•

E. Coli cells are harvested using LB Media.
As their colony grows, they will be
transferred into four conical tubes.
Through these tubes, they will have their
DNA mixed with four different kinds of
RNA oligos
Plasmid DNA is purified, with the filler
extracted from an agarose gel
The plasmid DNA is dephosphorylated and
opened for receiving the oligo
The oligo and plasmid DNA are annealed
together
The COS-1 cell and new oligo plasmid
DNA are mixed, creating the start of the
lentivirus
The lentivirus is then incubated with RL
human lymphoma cells along with
puromycin for a week
After puromycin selection, the cells can be
tested using T7E1 Assay and Western blot to
determine the efficiency of lentiCRISPRv2
and its guide RNA

Heat Shock

Bacterial DNA

Bacteria is heat
shocked and mixed
with a ligation buffer
and plasmid DNA

Plasmid DNA

Bacteria with
plasmid DNA is
then placed on an
Ampilicin agar
plate and
incubated
Depicted are the four gCARM1 oligo sequencing. The U6 Promoter, gRNA scaffold and polIII terminator can be seen.

Conclusions
The puromycin selection went successful,
with the negative control being eradicated
after the first week. The surviving RL cells
are the ones with the lentiCRISPRv2
plasmid, meaning the living cells have been
correctly transfected with the puromycin
resistance gene. To test the accuracy of the
four guide RNA’s, the cells will be placed in
a T7E1 assay and Western Blot. T7E1 Assay
is used to investigate the efficiency of the
guide RNA’s. This is done by amplifying
the strands of DNA. It does this by
recognizing strands of DNA that were not
perfectly matched before cleaving them.
These strands of DNA can be amplified by
PCR. Each colony will be created from a
single cell clone, which means there will be
four colonies, but each colony comes from
one single cell clone. These clones will be
investigated using western blot. WB will
test for CARM1 and CBP.
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PCR +
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After the creation of the lentivirus using Cos-1 cells, the media is extracted and placed in two six well plates. The
first six well plate is RL WT cells and the second is RL CBP KO.

